- Home
- TSI vs ZYXI Comparison
TSI vs ZYXI Comparison
Compare TSI & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TSI | ZYXI |
|---|---|---|
| Founded | 1987 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 234.6M | 35.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TSI | ZYXI |
|---|---|---|
| Price | $4.96 | $0.31 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 106.8K | ★ 10.4M |
| Earning Date | 01-01-0001 | 11-17-2025 |
| Dividend Yield | ★ 7.46% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $108,202,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.48 | $0.23 |
| 52 Week High | $4.87 | $8.72 |
Technical Indicators
Market Signals| Indicator | TSI | ZYXI |
|---|---|---|
| Relative Strength Index (RSI) | 58.82 | 33.70 |
| Support Level | $4.90 | $0.23 |
| Resistance Level | $4.96 | $0.95 |
| Average True Range (ATR) | 0.04 | 0.15 |
| MACD | 0.00 | -0.07 |
| Stochastic Oscillator | 90.48 | 6.88 |
Price Performance
Historical ComparisonAbout TSI TCW Strategic Income Fund Inc.
Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment and others.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.